Oryzon Genomics - EC taps Oryzon for healthcare initiative
The European Commission has selected Oryzon to support a new healthcare initiative furthering innovation in the region. As an associated partner of...
361 Views
Oryzon Genomics - Doubling down on clinical activity in 2024
Oryzon’s Q124 results emphasised the company’s focus on advancing and expanding its CNS and oncology pipelines, driven by its core assets,...
345 Views
Oryzon Genomics - FDA green light for SCLC combination trial
With the FDA investigational new drug (IND) application clearance, Oryzon can commence its Phase I/II cooperative research and development...
415 Views
Oryzon Genomics - Third time is a charm; INNOVATIVE SME Seal
For the third consecutive time, Oryzon Genomics has received the INNOVATIVE SME Seal from the Spanish Ministry of Science and Innovation. This...
449 Views
Oryzon Genomics - Approaching a period of inflection
ORY FY23 results announcement covered an eventful period for the company’s pipeline, capped by the release of top-line data from the Phase IIb...
314 Views